Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status.

Haas JS, Hill DA, Wellman RD, Hubbard RA, Lee CI, Wernli KJ, Stout NK, Tosteson AN, Henderson LM, Alford-Teaster JA, Onega TL.

Cancer. 2016 Feb 15;122(4):611-7. doi: 10.1002/cncr.29805. Epub 2015 Dec 28.

PMID:
26709819
2.

Predictors of Non-Adherence to Breast Cancer Screening among Hospitalized Women.

Khaliq W, Aamar A, Wright SM.

PLoS One. 2015 Dec 28;10(12):e0145492. doi: 10.1371/journal.pone.0145492. eCollection 2015.

3.

SNPs and breast cancer risk prediction for African American and Hispanic women.

Allman R, Dite GS, Hopper JL, Gordon O, Starlard-Davenport A, Chlebowski R, Kooperberg C.

Breast Cancer Res Treat. 2015 Dec;154(3):583-9. doi: 10.1007/s10549-015-3641-7. Epub 2015 Nov 20.

4.

MRI screening for breast cancer in women at high risk; is the Australian breast MRI screening access program addressing the needs of women at high risk of breast cancer?

Schenberg T, Mitchell G, Taylor D, Saunders C.

J Med Radiat Sci. 2015 Sep;62(3):212-25. doi: 10.1002/jmrs.116. Epub 2015 Jul 22. Review.

5.
6.

Mammographic Breast Density and Common Genetic Variants in Breast Cancer Risk Prediction.

Lee CP, Choi H, Soo KC, Tan MH, Chay WY, Chia KS, Liu J, Li J, Hartman M.

PLoS One. 2015 Sep 24;10(9):e0136650. doi: 10.1371/journal.pone.0136650. eCollection 2015.

8.

Lifetime and 5 years risk of breast cancer and attributable risk factor according to Gail model in Iranian women.

Mohammadbeigi A, Mohammadsalehi N, Valizadeh R, Momtaheni Z, Mokhtari M, Ansari H.

J Pharm Bioallied Sci. 2015 Jul-Sep;7(3):207-11. doi: 10.4103/0975-7406.160020.

9.

Chemoprevention for Breast Cancer.

Pruthi S, Heisey RE, Bevers TB.

Ann Surg Oncol. 2015 Oct;22(10):3230-5. doi: 10.1245/s10434-015-4715-9. Epub 2015 Jul 23.

10.

My Lived Experiences Are More Important Than Your Probabilities: The Role of Individualized Risk Estimates for Decision Making about Participation in the Study of Tamoxifen and Raloxifene (STAR).

Holmberg C, Waters EA, Whitehouse K, Daly M, McCaskill-Stevens W.

Med Decis Making. 2015 Nov;35(8):1010-22. doi: 10.1177/0272989X15594382. Epub 2015 Jul 16.

11.

Breast Cancer Risk Assessment Among Low-Income Women of Color in Primary Care: A Pilot Study.

Anderson EE, Tejeda S, Childers K, Stolley MR, Warnecke RB, Hoskins KF.

J Oncol Pract. 2015 Jul;11(4):e460-7. doi: 10.1200/JOP.2014.003558. Epub 2015 Jun 2.

12.

An exercise trial targeting African-American women with metabolic syndrome and at high risk for breast cancer: Rationale, design, and methods.

Dash C, Makambi K, Wallington SF, Sheppard V, Taylor TR, Hicks JS, Adams-Campbell LL.

Contemp Clin Trials. 2015 Jul;43:33-8. doi: 10.1016/j.cct.2015.04.015. Epub 2015 May 8.

PMID:
25962889
13.

Predictors of preoperative MRI for breast cancer: differences by data source.

Loggers ET, Gao H, Gold LS, Kessler L, Etzioni R, Buist DS; ADVICE Investigators.

J Comp Eff Res. 2015 May 11:1-12. [Epub ahead of print]

PMID:
25960128
14.

Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk.

Quante AS, Whittemore AS, Shriver T, Hopper JL, Strauch K, Terry MB.

J Natl Cancer Inst. 2015 May 8;107(7). pii: djv124. doi: 10.1093/jnci/djv124. Print 2015 Jul.

15.

Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.

Reimers LL, Sivasubramanian PS, Hershman D, Terry MB, Greenlee H, Campbell J, Kalinsky K, Maurer M, Jayasena R, Sandoval R, Alvarez M, Crew KD.

Breast J. 2015 Jul-Aug;21(4):377-86. doi: 10.1111/tbj.12418. Epub 2015 Apr 16.

PMID:
25879521
16.

Twenty-five years of breast cancer risk models and their applications.

Gail MH.

J Natl Cancer Inst. 2015 Feb 26;107(5). pii: djv042. doi: 10.1093/jnci/djv042. Print 2015 May. No abstract available.

17.

JNCI and cancer prevention.

Dunn BK, Ghosh S, Kramer BS.

J Natl Cancer Inst. 2015 Feb 24;107(3). pii: djv021. doi: 10.1093/jnci/djv021. Print 2015 Mar.

18.

Prospective approach to breast cancer risk prediction in African American women: the black women's health study model.

Boggs DA, Rosenberg L, Adams-Campbell LL, Palmer JR.

J Clin Oncol. 2015 Mar 20;33(9):1038-44. doi: 10.1200/JCO.2014.57.2750. Epub 2015 Jan 26.

19.

Risk-benefit profiles of women using tamoxifen for chemoprevention.

Nichols HB, DeRoo LA, Scharf DR, Sandler DP.

J Natl Cancer Inst. 2014 Dec 3;107(1):354. doi: 10.1093/jnci/dju354. Print 2015 Jan.

20.

Current strategies for the prevention of breast cancer.

Advani P, Moreno-Aspitia A.

Breast Cancer (Dove Med Press). 2014 May 2;6:59-71. doi: 10.2147/BCTT.S39114. eCollection 2014. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk